Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 489

1.

Progress and challenges in TB vaccine development.

Voss G, Casimiro D, Neyrolles O, Williams A, Kaufmann SHE, McShane H, Hatherill M, Fletcher HA.

F1000Res. 2018 Feb 16;7:199. doi: 10.12688/f1000research.13588.1. eCollection 2018. Review.

2.

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis.

Gupta-Wright A, Tomlinson GS, Rangaka MX, Fletcher HA.

F1000Res. 2018 Feb 22;7:217. doi: 10.12688/f1000research.14088.1. eCollection 2018.

3.

Porphyromonas gingivalis: the gift of community involvement.

Fletcher HM.

Mol Oral Microbiol. 2018 Apr;33(2):111-112. doi: 10.1111/omi.12218. Epub 2018 Feb 20. No abstract available.

PMID:
29461020
4.

Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.

Stockdale L, Nash S, Nalwoga A, Painter H, Asiki G, Fletcher H, Newton R.

PLoS One. 2018 Feb 6;13(2):e0192086. doi: 10.1371/journal.pone.0192086. eCollection 2018.

5.

Role of extracytoplasmic function sigma factor PG1660 (RpoE) in the oxidative stress resistance regulatory network of Porphyromonas gingivalis.

Dou Y, Rutanhira H, Chen X, Mishra A, Wang C, Fletcher HM.

Mol Oral Microbiol. 2018 Feb;33(1):89-104. doi: 10.1111/omi.12204. Epub 2017 Dec 15.

6.

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium.

Front Immunol. 2017 Oct 4;8:1203. doi: 10.3389/fimmu.2017.01203. eCollection 2017. Review.

7.

Exercise-induced Fatigue in Severe Hypoxia after an Intermittent Hypoxic Protocol.

Twomey R, Wrightson J, Fletcher H, Avraam S, Ross E, Dekerle J.

Med Sci Sports Exerc. 2017 Dec;49(12):2422-2432. doi: 10.1249/MSS.0000000000001371.

PMID:
28708702
8.

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey DA, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, Fletcher HA.

Clin Vaccine Immunol. 2017 Sep 5;24(9). pii: e00142-17. doi: 10.1128/CVI.00142-17. Print 2017 Sep. Review.

9.

Clinical residual symptomatology and associated factors in multiple organ failure survivors: A long-term mortgage.

Rodríguez-Villar S, Rodríguez-García JL, Arévalo-Serrano J, Sánchez-Casado M, Fletcher H.

Rev Esp Anestesiol Reanim. 2017 Dec;64(10):550-559. doi: 10.1016/j.redar.2017.03.011. Epub 2017 May 23. English, Spanish.

PMID:
28549793
10.

A gaze independent hybrid-BCI based on visual spatial attention.

Egan JM, Loughnane GM, Fletcher H, Meade E, Lalor EC.

J Neural Eng. 2017 Aug;14(4):046006. doi: 10.1088/1741-2552/aa6bb2.

PMID:
28513478
11.

Factors associated with mercury levels in human placenta and the relationship to neonatal anthropometry in Jamaica and Trinidad & Tobago.

Ricketts P, Fletcher H, Voutchkov M.

Reprod Toxicol. 2017 Aug;71:78-83. doi: 10.1016/j.reprotox.2017.04.008. Epub 2017 Apr 28.

PMID:
28461241
13.

The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Tanner R, O'Shea MK, White AD, Müller J, Harrington-Kandt R, Matsumiya M, Dennis MJ, Parizotto EA, Harris S, Stylianou E, Naranbhai V, Bettencourt P, Drakesmith H, Sharpe S, Fletcher HA, McShane H.

Sci Rep. 2017 Mar 3;7:43478. doi: 10.1038/srep43478.

14.

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.

Andrews JR, Nemes E, Tameris M, Landry BS, Mahomed H, McClain JB, Fletcher HA, Hanekom WA, Wood R, McShane H, Scriba TJ, Hatherill M.

Lancet Respir Med. 2017 Apr;5(4):282-290. doi: 10.1016/S2213-2600(17)30060-7. Epub 2017 Feb 16.

PMID:
28215501
15.

Human Immunology of Tuberculosis.

Scriba TJ, Coussens AK, Fletcher HA.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TBTB2-0016-2016. Review.

PMID:
28155806
16.

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.

Rhodes SJ, Sarfas C, Knight GM, White A, Pathan AA, McShane H, Evans TG, Fletcher H, Sharpe S, White RG.

Clin Vaccine Immunol. 2017 Mar 6;24(3). pii: e00525-16. doi: 10.1128/CVI.00525-16. Print 2017 Mar.

17.

The TB vaccine H56+IC31 dose-response curve is peaked not saturating: Data generation for new mathematical modelling methods to inform vaccine dose decisions.

Rhodes SJ, Zelmer A, Knight GM, Prabowo SA, Stockdale L, Evans TG, Lindenstrøm T, White RG, Fletcher H.

Vaccine. 2016 Dec 7;34(50):6285-6291. doi: 10.1016/j.vaccine.2016.10.060. Epub 2016 Nov 2.

18.

Human Immunology of Tuberculosis.

Scriba TJ, Coussens AK, Fletcher HA.

Microbiol Spectr. 2016 Oct;4(5). doi: 10.1128/microbiolspec.TBTB2-0016-2016. Review.

PMID:
27740453
19.

Human Immunology of Tuberculosis.

Scriba TJ, Coussens AK, Fletcher HA.

Microbiol Spectr. 2016 Aug;4(4). doi: 10.1128/microbiolspec.TBTB2-0016-2016. Review.

PMID:
27726784
20.

Polyfunctional CD4 T-cells correlate with in vitro mycobacterial growth inhibition following Mycobacterium bovis BCG-vaccination of infants.

Smith SG, Zelmer A, Blitz R, Fletcher HA, Dockrell HM.

Vaccine. 2016 Oct 17;34(44):5298-5305. doi: 10.1016/j.vaccine.2016.09.002. Epub 2016 Sep 9.

Supplemental Content

Loading ...
Support Center